US government promises Maryland drug manufacturer $628M to make coronavirus vaccines

The U.S. government has recruited contract drug manufacturer Emergent BioSolutions to aid in its ambitious efforts to develop, make and distribute a coronavirus vaccine by early next year, announcing Monday plans to pay the Maryland-based company more than half a billion dollars for vaccine production and assembly.